As a part of studying to develop B subtilis for prophylaxis and treatment of nasopharyngeal infections, we have preliminarily clinical trials the treatment effects of intranasal preparation from B subtilis (BASUBIN) for volunteer patients at department of Rhinosinus of Otorhinolaryngology Hospital at HoChiMinh City from September 28 to November 5, 2004.